GC
Fund 13F filing
GLENVIEW CAPITAL MANAGEMENT, LLC cut $40.7M of Biogen Inc. (BIIB) stock
GLENVIEW CAPITAL MANAGEMENT, LLC cut $40.7M of Biogen Inc. (BIIB) stock in the quarter ending Mar 31, 2026, per a 13F filed May 15, 2026.
A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.
- Disclosed
- May 15, 2026
- Quarter end
- Mar 31, 2026
- Source
- SEC Form 13F
More BIIB insider and Congress trades
More changes from this filing
From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.